GlassScriptPhysician profile
Tracie Costa
NPI 1881975878
$1,044.69
in general payments reported to CMS, 2019-2025
17 companies · $21.13 in 2025
The $21.13 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $543 · 2022: $176 · 2023: $290 · 2024: $13.88 · 2025: $21.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $166.63 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.71 | 2021-2023 | Stiolto Respimat, Spiriva Respimat |
| Pfizer INC. | $127.73 | 2021-2023 | |
| Mylan Specialty L.P. | $114.72 | 2021-2022 | |
| Abbvie INC. | $90.39 | 2021-2025 | |
| Exact Sciences Corporation | $86.50 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.38 | 2021-2023 | Xifaxan |
| Covis Pharma Gmbh | $42.87 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $39.17 | 2021 | |
| Novartis Pharmaceuticals Corporation | $37.67 | 2021 | |
| Medtronic, INC. | $24.86 | 2023 | Venaseal |
| Genentech USA, INC. | $24.30 | 2021 | |
| Exeltis, USA INC. | $22.99 | 2023 | Slynd |
| Redhill Biopharma INC. | $22.78 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.82 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $21.28 | 2023 | Ibsrela |
| Lucid Diagnostics INC. | $15.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracie Costa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.